Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | Anti-GPRC5D CAR-T cells |
| Synonyms | |
| Therapy Description |
Anti-GPRC5D CAR-T cells are T-cells engineered to express a chimeric antigen receptor (CAR) targeting GPRC5D (NCI Thesaurus). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| Anti-GPRC5D CAR-T cells | GPRC5D CAR T-cells|Anti-GPRC5D CAR T cells | GPRC5D Immune Cell Therapy 5 | Anti-GPRC5D CAR-T cells are T-cells engineered to express a chimeric antigen receptor (CAR) targeting GPRC5D (NCI Thesaurus). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT07874334 | Phase I | Anti-GPRC5D CAR-T cells | Phase 1a/b Study of GPRC5D CART Therapy in Relapsed/Refractory Multiple Myeloma and Light-chain Amyloidosis | Not yet recruiting | ISR | 0 |